Patent ID: 7642262

Claim:
A method for the alleviation or treatment of symptoms due to neurodegenerative diseases which are selected from the group consisting of Parkinson's disease and amyotrophic lateral sclerosis comprising administering to a patient in need of such alleviation or treatment an effective amount of a pharmaceutical composition containing, as an effective ingredient, a compound having the formula (I) or its pharmaceutically acceptable salt, hydrate, or hydrate salt: wherein R 1 to R 4 independently represent a hydrogen atom, a halogen atom, a hydroxy group, an alkoxy group, an alkyl group, or an alkyl group substituted with a halogen atom, R 5 represents a hydrogen atom, an alkyl group, or an alkyl group substituted with a halogen atom, E 1 represents —NH, E 2 represents an oxygen atom, A represents a nitrogen atom, X represents a hydrogen atom, a halogen atom, an alkoxy group, an alkyl group, or an alkyl group substituted with a halogen atom, and Q represents a phenyl group, a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, a hydroxyl group, a C 1 to C 5 linear or branched alkoxy group, a C 1 to C 5 linear or branched alkyl group, a C 1 to C 5 linear or branched alkyl group substituted with a halogen atom, a phenoxy group, a phenoxy group substituted with a substituent selected from the group consisting of a halogen atom, a hydroxy group, a C 1 to C 5 linear or branched alkoxy group, a C 1 to C 5 linear or branched alkyl group, a C 1 to C 5 linear or branched alkyl group substituted with a halogen atom, a phenylmethyl group, or a phenylmethyl group substituted with a substituent selected from the group consisting of a halogen atom, a hydroxy group, a C 1 to C 5 linear or branched alkoxy group, a C 1 to C 5 linear or branched alkyl group, a C 1 to C 5 linear or branched alkyl group substituted with a halogen atom, and a carrier therefor.